{"id":12609,"date":"2026-04-06T12:51:11","date_gmt":"2026-04-06T19:51:11","guid":{"rendered":"https:\/\/projectoutlier.com\/?p=12609"},"modified":"2026-04-21T09:50:40","modified_gmt":"2026-04-21T16:50:40","slug":"why-so-many-commercial-launches-miss-the-mark-and-how-technology-can-change-that","status":"publish","type":"post","link":"https:\/\/projectoutlier.com\/?p=12609","title":{"rendered":"Why So Many Commercial Launches Miss the Mark\u2014And How Technology Can Change That"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"12609\" class=\"elementor elementor-12609\" data-elementor-settings=\"{&quot;ha_cmc_init_switcher&quot;:&quot;no&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-30fcf5fa e-flex e-con-boxed wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no wpr-equal-height-no e-con e-parent\" data-id=\"30fcf5fa\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;_ha_eqh_enable&quot;:false}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-3c6bf68e elementor-widget elementor-widget-text-editor\" data-id=\"3c6bf68e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h2 class=\"blog-single-title\">Why So Many Commercial Launches Miss the Mark\u2014And How Technology Can Change That<\/h2><p>Despite groundbreaking science and significant investment, more than half of biotech launches underperform against expectations. The causes are rarely scientific. Instead, they\u2019re operational: poor cross-functional alignment, unclear go-to-market strategies, and a lack of scalable infrastructure.<\/p><p>At Project Outlier, we work with emerging biotechs launching their first commercial product, navigating the complex shift from clinical to commercial. The challenges they face are well articulated in the recent Life Science Leader article, \u201cWhy So Many Biotech Launches Miss Expectations, And How To Fix It.\u201d The article\u2019s insights mirror what we\u2019ve seen time and again\u2014and where we believe the right technology strategy can make a difference.<\/p><p>Here\u2019s how we think about solving the biotech launch problem:<\/p><h4>1. Start Commercial Readiness Early\u2014Not 18 Months Before Launch<\/h4><p>All too often, we see commercialization treated as an end-of-phase function. Planning begins 12\u201318 months before PDUFA, with fragmented efforts to stand up critical functions\u2014market access, field deployment, analytics, systems\u2014under intense time pressure. It\u2019s a recipe for shortfalls.<\/p><p>Instead, commercial readiness should be integrated across the clinical development lifecycle. This includes mapping out technology systems that will scale with the organization, establishing enterprise data models, and implementing tools that enable early HCP and KOL engagement strategies.<\/p><p>We advise biotechs to treat commercial planning as a parallel track, not a milestone.<\/p><h4>2. Use Technology to Align Functions\u2014Not Create More Silos<\/h4><p>The article rightly highlights a hidden but critical launch risk: misalignment across functions. Commercial, medical affairs, access, marketing, regulatory, and IT often operate in their own swim lanes, leading to conflicting messaging, disconnected timelines, and redundant effort.<\/p><p>Technology can help\u2014but only if it\u2019s implemented strategically. That means:<br \/>Using collaborative work management platforms to ensure visibility and accountability<\/p><p>Integrating data from Medical Affairs, MSLs, and Commercial into shared CRMs<\/p><p>Aligning content workflows across Veeva Vault, Salesforce, and omnichannel platforms<\/p><p>At Project Outlier, we ensure that every technology solution is designed to drive clarity, consistency, and cross-functional execution.<\/p><h4>3. Let Data Drive Precision in Launch Execution<\/h4><p>Successful launches today depend on real-time intelligence and agile execution. Traditional spray-and-pray field tactics are not only expensive\u2014they\u2019re ineffective.<\/p><p>We help clients deploy data platforms and AI-powered insights to:<br \/>Prioritize HCP targets based on referral behavior and digital engagement<br \/>Optimize channel mix through ongoing A\/B testing and CRM analytics<br \/>Refine payer strategy with predictive models on access and utilization trends<br \/>Biotechs don\u2019t need massive sales forces\u2014they need smarter ones. When powered by data, precision outweighs scale.<\/p><h4>4. Build a Scalable, Compliant Infrastructure That Won\u2019t Break on Day 1<\/h4><p>Finally, the operational backbone must be ready to handle the demands of launch. That includes validated GxP systems, quality documentation, ERP, CRM, PV systems, patient services platforms, and more.<\/p><p>Many companies attempt to patch systems together in the final stretch\u2014only to realize too late that:<br \/>Systems don\u2019t talk to each other<br \/>Field teams can\u2019t access the right content<\/p><h6>Quality, regulatory, and medical are operating off outdated information<\/h6><p>At Project Outlier, we build launch infrastructure that\u2019s fit for purpose and built to scale\u2014balancing compliance, usability, and cost-effectiveness.<\/p><h4>Conclusion: The Future of Launch Is Integrated<\/h4><p>Biotech companies are under intense pressure to deliver results\u2014and investors are watching. Missing launch expectations doesn\u2019t just hurt near-term revenue; it undermines trust, market credibility, and the momentum needed for future indications.<\/p><p>Technology won\u2019t fix everything\u2014but without it, the risks multiply. Biotechs must treat systems, data, and process alignment as central to their launch strategy\u2014not secondary.<\/p><p>At Project Outlier, we partner with emerging life sciences organizations to build the connective tissue needed for commercial success. If your organization is planning a launch\u2014or struggling to recover from one that underperformed\u2014we\u2019d love to help.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Why So Many Commercial Launches Miss the Mark\u2014And How Technology Can Change That Despite groundbreaking science and significant investment, more than half of biotech launches underperform against expectations. The causes are rarely scientific. Instead, they\u2019re operational: poor cross-functional alignment, unclear go-to-market strategies, and a lack of scalable infrastructure. At Project Outlier, we work with emerging biotechs launching their first commercial product, navigating the complex shift from clinical to commercial. The[&hellip;]<\/p>\n","protected":false},"author":15,"featured_media":13425,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"content-type":"","footnotes":""},"categories":[139,156,164,140],"tags":[],"class_list":["post-12609","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog-post","category-commercial-it","category-commercial-launch","category-it-strategy-blog"],"acf":[],"jetpack_featured_media_url":"https:\/\/projectoutlier.com\/wp-content\/uploads\/2026\/04\/freelance-typing-write-prompt-ai_68335832.jpg","rttpg_featured_image_url":{"full":["https:\/\/projectoutlier.com\/wp-content\/uploads\/2026\/04\/freelance-typing-write-prompt-ai_68335832.jpg",1904,1009,false],"landscape":["https:\/\/projectoutlier.com\/wp-content\/uploads\/2026\/04\/freelance-typing-write-prompt-ai_68335832.jpg",1904,1009,false],"portraits":["https:\/\/projectoutlier.com\/wp-content\/uploads\/2026\/04\/freelance-typing-write-prompt-ai_68335832.jpg",1904,1009,false],"thumbnail":["https:\/\/projectoutlier.com\/wp-content\/uploads\/2026\/04\/freelance-typing-write-prompt-ai_68335832-150x150.jpg",150,150,true],"medium":["https:\/\/projectoutlier.com\/wp-content\/uploads\/2026\/04\/freelance-typing-write-prompt-ai_68335832-300x159.jpg",300,159,true],"large":["https:\/\/projectoutlier.com\/wp-content\/uploads\/2026\/04\/freelance-typing-write-prompt-ai_68335832-1024x543.jpg",847,449,true],"1536x1536":["https:\/\/projectoutlier.com\/wp-content\/uploads\/2026\/04\/freelance-typing-write-prompt-ai_68335832-1536x814.jpg",1536,814,true],"2048x2048":["https:\/\/projectoutlier.com\/wp-content\/uploads\/2026\/04\/freelance-typing-write-prompt-ai_68335832.jpg",1904,1009,false],"cspt-img-800x770":["https:\/\/projectoutlier.com\/wp-content\/uploads\/2026\/04\/freelance-typing-write-prompt-ai_68335832-800x770.jpg",800,770,true],"cspt-img-600x800":["https:\/\/projectoutlier.com\/wp-content\/uploads\/2026\/04\/freelance-typing-write-prompt-ai_68335832-600x800.jpg",600,800,true],"cspt-img-1030x570":["https:\/\/projectoutlier.com\/wp-content\/uploads\/2026\/04\/freelance-typing-write-prompt-ai_68335832-1030x570.jpg",1030,570,true],"cspt-img-600x700":["https:\/\/projectoutlier.com\/wp-content\/uploads\/2026\/04\/freelance-typing-write-prompt-ai_68335832-600x700.jpg",600,700,true],"cspt-img-770x635":["https:\/\/projectoutlier.com\/wp-content\/uploads\/2026\/04\/freelance-typing-write-prompt-ai_68335832-770x635.jpg",770,635,true],"cspt-img-770x500":["https:\/\/projectoutlier.com\/wp-content\/uploads\/2026\/04\/freelance-typing-write-prompt-ai_68335832-770x500.jpg",770,500,true],"cspt-img-770x9999":["https:\/\/projectoutlier.com\/wp-content\/uploads\/2026\/04\/freelance-typing-write-prompt-ai_68335832-770x408.jpg",770,408,true],"cspt-img-770x770":["https:\/\/projectoutlier.com\/wp-content\/uploads\/2026\/04\/freelance-typing-write-prompt-ai_68335832-770x770.jpg",770,770,true],"cspt-img-300x300":["https:\/\/projectoutlier.com\/wp-content\/uploads\/2026\/04\/freelance-typing-write-prompt-ai_68335832-300x300.jpg",300,300,true],"cspt-img-1200x600":["https:\/\/projectoutlier.com\/wp-content\/uploads\/2026\/04\/freelance-typing-write-prompt-ai_68335832-1200x600.jpg",1200,600,true],"cspt-img-770x400":["https:\/\/projectoutlier.com\/wp-content\/uploads\/2026\/04\/freelance-typing-write-prompt-ai_68335832-770x400.jpg",770,400,true],"cspt-img-590x550":["https:\/\/projectoutlier.com\/wp-content\/uploads\/2026\/04\/freelance-typing-write-prompt-ai_68335832-590x550.jpg",590,550,true],"cspt-img-800x256":["https:\/\/projectoutlier.com\/wp-content\/uploads\/2026\/04\/freelance-typing-write-prompt-ai_68335832-800x256.jpg",800,256,true],"cspt-img-720x540":["https:\/\/projectoutlier.com\/wp-content\/uploads\/2026\/04\/freelance-typing-write-prompt-ai_68335832-720x540.jpg",720,540,true],"cspt-img-560x350":["https:\/\/projectoutlier.com\/wp-content\/uploads\/2026\/04\/freelance-typing-write-prompt-ai_68335832-560x350.jpg",560,350,true],"cspt-img-800x670":["https:\/\/projectoutlier.com\/wp-content\/uploads\/2026\/04\/freelance-typing-write-prompt-ai_68335832-800x670.jpg",800,670,true],"cspt-img-750x950":["https:\/\/projectoutlier.com\/wp-content\/uploads\/2026\/04\/freelance-typing-write-prompt-ai_68335832-750x950.jpg",750,950,true],"cspt-img-660x480":["https:\/\/projectoutlier.com\/wp-content\/uploads\/2026\/04\/freelance-typing-write-prompt-ai_68335832-660x480.jpg",660,480,true]},"rttpg_author":{"display_name":"Erin Walter","author_link":"https:\/\/projectoutlier.com\/author\/erinwalter"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/projectoutlier.com\/?cat=139\" rel=\"category\">Blog<\/a> <a href=\"https:\/\/projectoutlier.com\/?cat=156\" rel=\"category\">Commercial IT<\/a> <a href=\"https:\/\/projectoutlier.com\/?cat=164\" rel=\"category\">Commercial Launch<\/a> <a href=\"https:\/\/projectoutlier.com\/?cat=140\" rel=\"category\">IT Strategy<\/a>","rttpg_excerpt":"Why So Many Commercial Launches Miss the Mark\u2014And How Technology Can Change That Despite groundbreaking science and significant investment, more than half of biotech launches underperform against expectations. The causes are rarely scientific. Instead, they\u2019re operational: poor cross-functional alignment, unclear go-to-market strategies, and a lack of scalable infrastructure. At Project Outlier, we work with emerging&hellip;","_links":{"self":[{"href":"https:\/\/projectoutlier.com\/index.php?rest_route=\/wp\/v2\/posts\/12609","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/projectoutlier.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/projectoutlier.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/projectoutlier.com\/index.php?rest_route=\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/projectoutlier.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=12609"}],"version-history":[{"count":13,"href":"https:\/\/projectoutlier.com\/index.php?rest_route=\/wp\/v2\/posts\/12609\/revisions"}],"predecessor-version":[{"id":13756,"href":"https:\/\/projectoutlier.com\/index.php?rest_route=\/wp\/v2\/posts\/12609\/revisions\/13756"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/projectoutlier.com\/index.php?rest_route=\/wp\/v2\/media\/13425"}],"wp:attachment":[{"href":"https:\/\/projectoutlier.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=12609"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/projectoutlier.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=12609"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/projectoutlier.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=12609"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}